Compass Pathways (MEX:CMPSN) Accounts Payable: MXN213.58 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:CMPSN Compass Pathways PLC MEX:CMPSN
12 GF Score
Price MXN242.00
! 1 Warning Sign
View Full Analysis

What is Compass Pathways Accounts Payable?

Compass Pathways MEX:CMPSN 12 Accounts Payable is MXN213.58 Mil as of Jun. 2026. GuruFocus rates MEX:CMPSN with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

Compass Pathways's Accounts Payable for the quarter that ended in Jun. 2026 was MXN213.58 Mil.

Compass Pathways's quarterly Accounts Payable declined from Dec. 2025 (MXN274.08 Mil) to Mar. 2026 (MXN196.14 Mil) but then increased from Mar. 2026 (MXN196.14 Mil) to Jun. 2026 (MXN213.58 Mil).

Compass Pathways's annual Accounts Payable increased from Dec. 2023 (MXN100.01 Mil) to Dec. 2024 (MXN256.17 Mil) and increased from Dec. 2024 (MXN256.17 Mil) to Dec. 2025 (MXN274.08 Mil).

Compass Pathways Accounts Payable Related Terms

Compass Pathways Accounts Payable Historical Data

* Premium members only.

The historical data trend for Compass Pathways's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Compass Pathways Accounts Payable Chart

Compass Pathways Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial 52.60 92.82 100.01 256.17 274.08

Compass Pathways Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 205.71 96.23 274.08 196.14 213.58
MEX:CMPSN
12GF Score
Compass Pathways PLC MEX:CMPSN
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Compass Pathways Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of MXN213.58 Mil mean?
Compass Pathways (MEX:CMPSN) has a Accounts Payable of MXN213.58 Mil as of Jun. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Compass Pathways and its competitors.
Is Compass Pathways' Accounts Payable too high?
Compass Pathways' current Accounts Payable is MXN213.58 Mil. Overall, Compass Pathways has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Compass Pathways' Accounts Payable compare to ARDT and HCSG?
Compass Pathways' Accounts Payable of MXN213.58 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Healthcare Providers & Services company?
A good Accounts Payable depends on the Healthcare Providers & Services industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Compass Pathways and its competitors. Compass Pathways's current Accounts Payable is MXN213.58 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Compass Pathways stock overvalued right now?
Compass Pathways (MEX:CMPSN) has a current Accounts Payable of MXN213.58 Mil. The current Accounts Payable is MXN213.58 Mil. Compass Pathways' overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Compass Pathways (MEX:CMPSN), the current Accounts Payable is MXN213.58 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Compass Pathways Business Description

Other Exchanges CMPS:USA5Y6:Germany
Address 33 Broadwick Street, London, GBR, W1F 0DQ
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.
12GF Score

Get the complete analysis for MEX:CMPSN

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN242.00
Price